AI-generated summary
The authors report a randomized study of 138 patients after tympanomastoidectomy, comparing laser photobiomodulation plus routine drugs with routine drugs alone. The PBM group had lower pain scores and headache-related disability at session 5 and at one and three months, but no immediate pain effect was seen. The abstract does not describe blinding or long-term follow-up beyond three months.
- Participants
- 138
- Who or what was studied
- Patients who had undergone tympanomastoidectomy surgery, randomly assigned to a photobiomodulation group (n=64) or a control group (n=64)
- Wavelengths
- 980 nm
- Limits stated in the abstract
- The abstract does not report blinding, and it offers no detail on the control group's pain management beyond routine drugs.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 980 nm
- Energy density (fluence)
- 8 j/cm2
- Power
- 50 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Visual analogue scale, Control group, Effect size, Trial registration, Wavelength, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.